News Nov 18, 2024 Alimentiv Partners on a New Alcoholic Hepatitis Phase 1b Clinical Trial September 2024 – Alimentiv is proud to partner on an exciting new Phase 1b clinical trial in severe alcohol-associated hepatitis, an area with high mortality… Read Now
Interview Jul 19, 2024 Expanding the Alimentiv Site Network: An Interview With Peter Westerveld The Alimentiv Site Network (ASN) is our worldwide network of gastrointestinal (GI) centers that collaborate with us. With an established global reputation for high-quality monitoring… Read Now
Publication Sep 8, 2017 Placebo response and remission rates in randomised trials of induction and maintenance therapy for ulcerative colitis Read Now
Publication Aug 3, 2017 Evolving Concepts in Phases I and II Drug Development for Crohn’s Disease Read Now
Publication Jul 29, 2017 Reliability of EUS indices to detect inflammation in ulcerative colitis Read Now
Publication Jul 21, 2017 Histologic scoring indices for evaluation of disease activity in Crohn’s disease Read Now
Publication Jun 27, 2017 The development of a magnetic resonance imaging index for fistulising Crohn’s disease Read Now